WO2025219870 - MODIFIED CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2025/219870
Publication Date
23.10.2025
International Application No.
PCT/IB2025/053926
International Filing Date
15.04.2025
Title **
[English]
MODIFIED CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL AND USES THEREOF
[French]
LYMPHOCYTE T À RÉCEPTEUR ANTIGÉNIQUE CHIMÉRIQUE (CAR) CIBLANT CD19 MODIFIÉ ET SES UTILISATIONS
Applicants **
BIOCELL INNOVATIONS PTE LTD
Inventors
LAM, Paula
FAZIL, Mobashar Hussain Urf Turabe
Priority Data
2024901053
15.04.2024
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3509 | |
| EPO | Filing, Examination, Granting | 29876 | |
| Japan | Filing, Examination, Granting | 3167 | |
| South Korea | Filing, Examination, Granting | 4183 | |
| USA | Filing, Examination, Granting | 14790 |
Total:
55,525
Contact Us
Abstract[English]
The present disclosure relates to chimeric antigen receptor (CAR) comprising an extracellular antigen binding domain comprising a modified single chain variable fragment (scFv) that specifically recognizes human cluster of differentiation 19 (CD 19) antigen. The present disclosure also relates to a polynucleotide encoding the CAR, vectors, genetically modified cells and uses thereof.[French]
La présente divulgation concerne un récepteur antigénique chimérique (CAR) comprenant un domaine de liaison à l'antigène extracellulaire comportant un fragment variable à chaîne unique modifié (scFv) qui reconnaît spécifiquement un antigène humain de classe de différenciation 19 (CD 19). La présente divulgation concerne également un polynucléotide codant pour le CAR, des vecteurs, des cellules génétiquement modifiées et leurs utilisations.